Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Netakimab in Active Ankylosing Spondylitis
NCT02763111Phase 2Completed
- Sponsor
- BIOCAD
- Start
- Sep 2016
- Primary completion
- Jun 2017
- Modality
- Recombinant Proteins and Enzymes, Monoclonal Antibodies
01
Overview
A Phase 2 trial of netakimab in ankylosing spondylitis (AS), sponsored by BIOCAD. Started Sep 2016; status: completed.
02
Drugs
netakimab
03
Conditions
ankylosing spondylitis (AS)
Beyond the preview
Go deeper on NCT02763111.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02763111.